Compounds identification and mechanism prediction of YuXueBi capsule in the treatment of arthritis by integrating UPLC/IM-QTOF-MS and network pharmacology.

Researchers investigated YuXueBi capsule (YXBC), a traditional Chinese herbal medicine widely used to treat rheumatoid arthritis in China. Rheumatoid arthritis is a chronic autoimmune condition causing joint pain, swelling, and reduced quality of life. While YXBC has been used effectively in clinical practice, scientists wanted to understand exactly which chemical compounds it contains and how it works in the body.

Using advanced laboratory techniques, the research team identified 58 different chemical compounds in YXBC. They then gave the capsule to rats and analyzed their blood, finding 16 of these compounds were absorbed into the bloodstream. These 16 compounds are likely the active ingredients responsible for the medicine's therapeutic effects.

Through computer-based network pharmacology analysis, researchers discovered these compounds work through 146 different biological targets in the body, affecting 30 important pathways involved in inflammation, pain, and blood circulation. The pathways include those related to immune system regulation and inflammatory responses, which are particularly relevant to rheumatoid arthritis.

This study provides scientific evidence explaining why YXBC works for arthritis patients. The herbal formula appears to reduce inflammation, relieve pain, and improve blood circulation through multiple mechanisms simultaneously. This multi-target approach is characteristic of traditional Chinese medicine and may explain why some patients find relief with herbal treatments when conventional medications provide incomplete results.

While this research focused on a Chinese patent medicine rather than acupuncture specifically, it represents the broader integration of traditional and modern scientific approaches to understanding arthritis treatment. If you're considering any traditional Chinese medicine approach for arthritis, consult with a qualified, licensed acupuncturist or traditional Chinese medicine practitioner who can provide personalized treatment recommendations.

This study employed UPLC/IM-QTOF-MS combined with network pharmacology to elucidate the active compounds and mechanisms of YuXueBi capsule (YXBC) in rheumatoid arthritis treatment. Researchers identified 58 compounds in YXBC, with 16 prototype compounds detected in rat serum following oral administration, indicating bioavailability and potential therapeutic activity.

Network pharmacology analysis revealed these absorbed compounds interact with 146 targets, modulating 30 key pathways including HIF-1 signaling, IL-17 signaling, and neuroactive ligand-receptor interaction. The multi-target, multi-pathway approach aligns with TCM principles of promoting blood circulation, removing blood stasis, and providing anti-inflammatory and analgesic effects.

Clinical significance: This research provides pharmacological evidence supporting YXBC's traditional use in RA, demonstrating its systemic immunomodulatory and anti-inflammatory mechanisms. The identification of bioavailable compounds offers potential biomarkers for quality control and clinical monitoring. For practitioners integrating Chinese herbal medicine, this study reinforces the scientific basis for blood-activating, stasis-removing formulas in inflammatory arthropathies, supporting evidence-informed herbal prescribing alongside acupuncture protocols.